From: Immunity as a predictor of anti-malarial treatment failure: a systematic review
Malaria treatment outcome | Description |
---|---|
Early treatment failure (ETF) | |
 Development of danger signs or severe malaria on days 1, 2 or 3, in the presence of parasitaemia | |
 Parasitaemia on day 2 higher than day 0 count, irrespective of axillary temperature | |
 Parasitaemia on day 3 with axillary temperature of ≥37.5 °C | |
 Parasitaemia of day 3 ≥25% of day 0 count | |
Late treatment failure | |
 Late clinical failure (LCF) | |
  Development of danger signs or severe malaria after day 3 in presence of parasitaemia | |
  Presence of parasitaemia and axillary temperature ≥37.5 °C on any day from day 4 to 14 (day 28 in low transmission areas), without previously meeting any of the criteria of ETF | |
 Late parasitological failure (LPF) | |
  Presence of parasitaemia on day 14 (any day from day 7 to 28 in low transmission areas), and axillary temperature ≥37.5 °C, without previously meeting any of the criteria of ETF or LCF | |
Adequate clinical and parasitological response (ACPR) | |
 Absence of parasitaemia on day 28 irrespective of axillary temperature without previously meeting any of the criteria of ETF or LCF or LPF |